Department of Pharmacy, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.
Department of Pharmacy, Uganda Cancer Institute, Mbarara, Uganda.
BMC Public Health. 2024 Jan 6;24(1):111. doi: 10.1186/s12889-023-17532-4.
Coronavirus disease (COVID-19) vaccine hesitancy is a global challenge. In low- and middle-income countries (LMICs), the problem has persisted despite vaccine availability and decreasing infections. In Uganda, there is still limited information on the extent and predictors of vaccine hesitancy. This study sought to assess the prevalence and predictors of COVID-19 vaccine hesitancy, and the effectiveness of an intervention that involved community pharmacy counseling in combating COVID-19 vaccine hesitancy.
A total of 394 participants were enrolled in a 4-week prospective cohort interventional study. The study was conducted across eight community pharmacies in Mbarara City, between 9:00 AM and 5:00 PM daily. The study personnel ascertained the vaccination status of all clients seeking community pharmacy services. All unvaccinated clients were consecutively assessed for eligibility, and eligible clients were systematically enrolled after receiving the community pharmacy services for which they requested. The study intervention involved structured participant counseling (within the pharmacy premise), follow-up short message service (weekly), and telephone calls (bi-weekly). Only participants who did not accept to receive the COVID-19 vaccine despite counseling were followed up for four weeks, or until they accepted to receive a COVID-19 vaccine. The effectiveness of the community pharmacy counseling intervention was determined as an increase in COVID-19 vaccine acceptance, and desirable attitudinal change towards COVID-19 disease, vaccination exercise, and vaccines. Descriptive analysis was used to summarize data, and multivariate analysis was used to determine the predictors of COVID-19 vaccine hesitancy. A p-value < 0.05 was considered statistically significant.
Out of 394 participants, 221 (56%) were hesitant to receive a COVID-19 vaccine. Participants expressed several reasons (mean 2±1) for COVID-19 vaccine hesitancy, mostly concerning vaccine safety (N=160, 47.3%). The overall COVID-19 vaccine acceptance rate increased by 25.4 percent points (43.9 - 69.3 percent points) after the study intervention. Age, religion, level of education, distance from the nearest public health facility, having a friend/family diagnosed with COVID-19, and personal suspicion of contracting COVID-19 were significant predictors of COVID-19 vaccine hesitancy.
COVID-19 vaccine hesitancy is a big challenge in Uganda. A mix of sociodemographic and COVID-19 vaccine perceptions are the key predictors of COVID-19 vaccine hesitancy. Although COVID-19 vaccines were not available at the time of the study, this study found that structured counseling interventions can improve COVID-19 vaccine acceptance rates. Larger prospective studies should evaluate the effectiveness of similar interventions in community pharmacies and other healthcare settings.
冠状病毒病(COVID-19)疫苗犹豫是一个全球性挑战。在低收入和中等收入国家(LMICs),尽管疫苗供应和感染人数减少,但问题仍然存在。在乌干达,关于 COVID-19 疫苗犹豫的程度和预测因素的信息仍然有限。本研究旨在评估 COVID-19 疫苗犹豫的流行程度和预测因素,以及涉及社区药房咨询以对抗 COVID-19 疫苗犹豫的干预措施的效果。
共有 394 名参与者参加了一项为期 4 周的前瞻性队列干预研究。该研究在姆巴拉拉市的 8 家社区药房进行,每天上午 9 点至下午 5 点。研究人员确定了所有寻求社区药房服务的客户的疫苗接种状况。所有未接种疫苗的客户都连续评估其资格,在接受他们要求的社区药房服务后,有资格的客户将被系统纳入。研究干预措施包括参与者的结构化咨询(在药房内)、每周的短期消息服务(SMS)和每两周的电话咨询。只有在咨询后仍拒绝接种 COVID-19 疫苗的参与者才会被随访 4 周,或直到他们同意接种 COVID-19 疫苗。社区药房咨询干预措施的效果确定为 COVID-19 疫苗接种率的提高,以及对 COVID-19 疾病、疫苗接种运动和疫苗的理想态度转变。使用描述性分析总结数据,使用多变量分析确定 COVID-19 疫苗犹豫的预测因素。p 值 < 0.05 被认为具有统计学意义。
在 394 名参与者中,有 221 名(56%)对接受 COVID-19 疫苗犹豫不决。参与者对 COVID-19 疫苗犹豫表示了几个原因(平均 2±1),主要涉及疫苗安全性(N=160,47.3%)。研究干预后,COVID-19 疫苗总体接种率提高了 25.4 个百分点(43.9-69.3 个百分点)。年龄、宗教、教育水平、与最近的公共卫生设施的距离、有朋友/家人被诊断患有 COVID-19 以及个人怀疑感染 COVID-19 是 COVID-19 疫苗犹豫的重要预测因素。
COVID-19 疫苗犹豫是乌干达的一大挑战。社会人口统计学和 COVID-19 疫苗认知是 COVID-19 疫苗犹豫的关键预测因素。尽管在研究时 COVID-19 疫苗不可用,但本研究发现,结构化咨询干预措施可以提高 COVID-19 疫苗接种率。应进行更大规模的前瞻性研究,以评估社区药房和其他医疗保健环境中类似干预措施的有效性。